Analysis of promoter methylation in stool: A novel method for the detection of colorectal cancer

Clinical Gastroenterology and Hepatology

Volumn 3, Issue 2, 2005, Pages 142-149

  Lenhard, Konstanze ^a   Bommer, Guido T ^a   Asutay, Silke ^a   Schauer, Rolf ^a   Brabletz, Thomas ^b   Göke, Burkhard ^a   Lamerz, Rolf ^a   Kolligs, Frank T ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CHRONIC INFLAMMATION; CLINICAL ARTICLE; CLINICAL TRIAL; COLONOSCOPY; COLORECTAL ADENOMA; COLORECTAL CANCER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DNA DETERMINATION; DNA METHYLATION; ENTERITIS; EPIGENETICS; FECES; FEMALE; HETEROZYGOTE; HUMAN; HYPERPLASIA; INTESTINE POLYP; MALE; MARKER GENE; OCCULT BLOOD; POLYMERASE CHAIN REACTION; PROMOTER REGION; SAMPLE; SENSITIVITY AND SPECIFICITY; ULCERATIVE COLITIS;

AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; BASE SEQUENCE; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; CONFIDENCE INTERVALS; DNA METHYLATION; DNA, NEOPLASM; FECES; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; OCCULT BLOOD; POLYMERASE CHAIN REACTION; PROMOTER REGIONS (GENETICS); PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SEX DISTRIBUTION; SINGLE-BLIND METHOD; TUMOR MARKERS, BIOLOGICAL;

EID: 13544257481     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1542-3565(04)00624-X     Document Type: Article

References (55)

1. A. Jemal, A. Thomas, T. Murray Cancer statistics CA Cancer J Clin 52 2002 23 47
2. C. McArdle ABC of colorectal cancer. Primary treatment-does the surgeon matter? BMJ 321 2000 1121 1123
3. K.W. Kinzler, B. Vogelstein Lessons from hereditary colorectal cancer Cell 87 1996 159 170
4. S.J. Winawer, A.G. Zauber, M.N. Ho National Polyp Study Workgroup Prevention of colorectal cancer by colonoscopic polypectomy N Engl J Med 329 1993 1977 1983
5. J.S. Mandel, J.H. Bond, T.R. Church Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study N Engl J Med 328 1993 1365 1371
6. J.D. Hardcastle, J.O. Chamberlain, M.H. Robinson Randomised controlled trial of faecal-occult-blood screening for colorectal cancer Lancet 348 1996 1472 1477
7. O. Kronborg, C. Fenger, J. Olsen Randomised study of screening for colorectal cancer with faecal-occult-blood test Lancet 348 1996 1467 1471
8. W. Burt Colon cancer screening Gastroenterology 119 2000 837 853
9. N. Breen, D.K. Wagener, M.L. Brown Progress in cancer screening over a decade results of cancer screening from the 1987, 1992, and 1998 National Health Interview Surveys J Natl Cancer Inst 93 2001 1704 1713
10. D. Sidransky, T. Tokino, S.R. Hamilton Identification of ras oncogene mutations in the stool of patients with curable colorectal tumors Science 256 1992 102 105
11. Y. Hasegawa, S. Takeda, S. Ichii Detection of K-ras mutations in DNAs isolated from feces of patients with colorectal tumors by mutant-allele-specific amplification (MASA) Oncogene 10 1995 1441 1445
12. J. Smith-Ravin, J. England, I.C. Talbot Detection of c-Ki-ras mutations in faecal samples from sporadic colorectal cancer patients Gut 36 1995 81 86
13. E. Villa, A. Dugani, A.M. Rebecchi Identification of subjects at risk for colorectal carcinoma through a test based on K-ras determination in the stool Gastroenterology 110 1996 1346 1353
14. P. Nollau, C. Moser, G. Weinland Detection of K-ras mutations in stools of patients with colorectal cancer by mutant-enriched PCR Int J Cancer 66 1996 332 336
15. P. Puig, E. Urgell, G. Capella A highly sensitive method for K-ras mutation detection is useful in diagnosis of gastrointestinal cancer Int J Cancer 85 2000 73 77
16. L. Prix, P. Uciechowski, B. Bockmann Diagnostic biochip array for fast and sensitive detection of K-ras mutations in stool Clin Chem 48 2002 428 435
17. S. Eguchi, N. Kohara, K. Komuta Mutations of the p53 gene in the stool of patients with resectable colorectal cancer Cancer 77 1996 1707 1710
18. G. Traverso, A. Shuber, B. Levin Detection of APC mutations in fecal DNA from patients with colorectal tumors N Engl J Med 346 2002 311 320
19. S.M. Dong, G. Traverso, C. Johnson Detecting colorectal cancer in stool with the use of multiple genetic targets J Natl Cancer Inst 93 2001 858 865
20. G. Traverso, A. Shuber, L. Olsson Detection of proximal colorectal cancers through analysis of faecal DNA Lancet 359 2002 403 404
21. D.A. Ahlquist, J.E. Skoletsky, K.A. Boynton Colorectal cancer screening by detection of altered human DNA in stool feasibility of a multitarget assay panel Gastroenterology 119 2000 1219 1227
22. S.B. Baylin, J.G. Herman DNA hypermethylation in tumorigenesis epigenetics joins genetics Trends Genet 16 2000 168 174
23. S.B. Baylin, S.A. Belinsky, J.G. Herman Aberrant methylation of gene promoters in cancer--concepts, misconcepts, and promise J Natl Cancer Inst 92 2000 1460 1461
24. J.G. Herman, J.R. Graff, S. Myöhänen Methylation-specific PCR a novel PCR assay for methylation status of CpG islands Proc Natl Acad Sci U S A 93 1996 9821 9826
25. P.W. Laird The power and the promise of DNA methylation markers Nat Rev Cancer 3 2003 253 266
26. D.A. Ahlquist, K.K. Klatt, J.J. Harrington Novel use of hypermethylated DNA markers in stool for detection of colorectal cancer a feasibility study Gastroenterology 122 2002 A40
27. H.M. Muller, M. Oberwalder, H. Fiegl Methylation changes in faecal DNA a marker for colorectal cancer screening? Lancet 363 2004 1283 1285
28. M.M. Wales, M.A. Biel, W.E. Deiry p53 activates expression of HIC-1, a new candidate tumour suppressor gene on 17p13.3 Nat Med 1 1995 570 577
29. W.Y. Chen, X. Zeng, M.G. Carter Heterozygous disruption of Hic1 predisposes mice to a gender-dependent spectrum of malignant tumors Nat Genet 33 2003 197 202
30. M. Maekawa, K. Sugano, M. Ushiama Heterogeneity of DNA methylation status analyzed by bisulfite-PCR-SSCP and correlation with clinico-pathological characteristics in colorectal cancer Clin Chem Lab Med 39 2001 121 128
31. N. Ahuja, Q. Li, A.L. Mohan Aging and DNA methylation in colorectal mucosa and cancer Cancer Res 58 1998 5489 5494
32. B. Vogelstein, K.W. Kinzler Digital PCR Proc Natl Acad Sci U S A 96 1999 9236 9241
33. R.G. Newcombe Two-sided confidence intervals for the single proportion comparison of seven methods Stat Med 17 1998 857 872
34. W.M. Grady, A. Rajput, J.D. Lutterbaugh Detection of aberrantly methylated hMLH1 promoter DNA in the serum of patients with microsatellite unstable colon cancer Cancer Res 61 2001 900 902
35. H.Z. Zou, B.M. Yu, Z.W. Wang Detection of aberrant p16 methylation in the serum of colorectal cancer patients Clin Cancer Res 8 2002 188 191
36. H. Nakayama, K. Hibi, M. Taguchi Molecular detection of p16 promoter methylation in the serum of colorectal cancer patients Cancer Lett 188 2002 115 119
37. C. Grunau, S.J. Clark, A. Rosenthal Bisulfite genomic sequencing systematic investigation of critical experimental parameters Nucleic Acids Res 29 2001 E65-5
38. D.A. Ahlquist, H.S. Wieand, C.G. Moertel Accuracy of fecal occult blood screening for colorectal neoplasia. A prospective study using Hemoccult and HemoQuant tests JAMA 269 1993 1262 1267
39. A. Loktionov, I.K. O'Neill, J.H. Cummings Quantitation of DNA from exfoliated colonocytes isolated from human stool surface as a novel non-invasive screening test for colorectal cancer Clin Cancer Res 4 1998 337 342
40. A.O. Chan, R.R. Broaddus, P.S. Houlihan CpG island methylation in aberrant crypt foci of the colorectum Am J Pathol 160 2002 1823 1830
41. M. Toyota, M. Ohe-Toyota, N. Ahuja Distinct genetic profiles in colorectal tumors with or without the CpG island methylator phenotype Proc Natl Acad Sci U S A 97 2000 710 715
42. L. Shen, J.-P.J. Issa Epigenetics in colorectal cancer Curr Opin Gastroenterol 18 2002 68 73
43. N. Ahuja, J.P. Issa Aging, methylation and cancer Histol Histopathol 15 2000 835 842
44. H. Suzuki, D.N. Watkins, K.W. Jair Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer Nat Genet 36 2004 417 422
45. R.G. Smith Southwestern internal medicine conference: hereditary predisposition to colorectal cancer: new insights Am J Med Sci 308 1994 295 308
46. J. Jen, S.M. Powell, N. Papadopoulos Molecular determinants of dysplasia in colorectal lesions Cancer Res 54 1994 5523 5526
47. T.P. Pretlow Aberrant crypt foci and K-ras mutations earliest recognized players or innocent bystanders in colon carcinogenesis? Gastroenterology 108 1995 600 603
48. C.J. Hsieh, B. Klump, K. Holzmann Hypermethylation of the p16INK4a promoter in colectomy specimens of patients with long-standing and extensive ulcerative colitis Cancer Res 58 1998 3942 3945
49. J.P. Issa, N. Ahuja, M. Toyota Accelerated age-related CpG island methylation in ulcerative colitis Cancer Res 61 2001 3573 3577
50. F. Sato, N. Harpaz, D. Shibata Hypermethylation of the p14(ARF) gene in ulcerative colitis-associated colorectal carcinogenesis Cancer Res 62 2002 1148 1151
51. F. Sato, D. Shibata, N. Harpaz Aberrant methylation of the HPP1 gene in ulcerative colitis-associated colorectal carcinoma Cancer Res 62 2002 6820 6822
52. A.O. Chan, J.P. Issa, J.S. Morris Concordant CpG island methylation in hyperplastic polyposis Am J Pathol 160 2002 529 536
53. C.V. Wynter, M.D. Walsh, T. Higuchi Methylation patterns define two types of hyperplastic polyp associated with colorectal cancer Gut 53 2004 573 580
54. J.G. Herman, A. Umar, K. Polyak Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma Proc Natl Acad Sci U S A 95 1998 6870 6875
55. J. Young, K.G. Biden, L.A. Simms HPP1 a transmembrane protein-encoding gene commonly methylated in colorectal polyps and cancers Proc Natl Acad Sci U S A 98 2001 265 270